Spyre Therapeutics
SYRE
#2075
Rank
ยฃ6.78 B
Marketcap
ยฃ71.45
Share price
-4.26%
Change (1 day)
285.64%
Change (1 year)

Earnings for Spyre Therapeutics (SYRE)

Earnings in 2026 (TTM): -ยฃ0.25 Billion

According to Spyre Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ0.17 Billion a decrease over its 2024 earnings that were of -ยฃ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spyre Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.25 Billion43.52%
2025 -ยฃ0.17 Billion5.27%
2024 -ยฃ0.16 Billion62.23%
2023 -ยฃ98.28 Million51.64%
2022 -ยฃ64.81 Million29.14%
2021 -ยฃ50.19 Million-19.43%
2020 -ยฃ62.29 Million1.43%
2019 -ยฃ61.41 Million76.7%
2018 -ยฃ34.76 Million64.27%
2017 -ยฃ21.16 Million26.34%
2016 -ยฃ16.75 Million93.6%
2015 -ยฃ8.65 Million27.08%
2014 -ยฃ6.81 Million